| Nov 1, 2021 |
Nov 3, 2021 |
Merck & Co., Inc.
|
EVP, Chief Patient Officer |
Sell |
16.3
|
-96,270
|
-71.08%
|
✗
|
$8.5M |
| Jul 17, 2020 |
Jul 20, 2020 |
Merck & Co., Inc.
|
EVP Strat Comm, GI Pub Policy |
Sell |
5.0
|
-36,285
|
-57.72%
|
✓
|
$2.9M |
| Jan 13, 2020 |
Jan 15, 2020 |
Merck & Co., Inc.
|
EVP Strat Comm, GI Pub Policy |
Sell |
3.8
|
-102,073
|
-73.38%
|
✓
|
$9.1M |
| Nov 7, 2018 |
Nov 8, 2018 |
Merck & Co., Inc.
|
EVP Strat Comm, Gl Pub Policy |
Sell |
17.5
|
-36,218
|
-43.91%
|
✗
|
$2.7M |
| May 15, 2018 |
May 16, 2018 |
Merck & Co., Inc.
|
EVP Strat Comm, Gl Pub Policy |
Sell |
20.0
|
-9,972
|
-17.91%
|
✗
|
$595K |
| May 2, 2017 |
May 3, 2017 |
Merck & Co., Inc.
|
EVP Strat Comm, Gl Pub Policy |
Sell |
22.5
|
-1,078
|
-2.32%
|
✗
|
$67.2K |